Market News Archive
Stay updated with the latest announcements
MAGURAPLEX: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.45 for January-March 2026 as against Tk. 1.49 for January-March 2025; EPS was Tk. 2.04 for July 2025-March 2026 as against Tk. 3.21 for July 2024-March 2025. NOCFPS was Tk. 1.50 for July 2025-March 2026 as against Tk. (1.28) for July 2024-March 2025. NAV per share was Tk. 75.73 as on March 31, 2026 and Tk. 74.79 as on June 30, 2025. (cont.)
MONNOCERA: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.07) for January-March 2026 as against Tk. 1.02 for January-March 2025; EPS was Tk. 0.24 for July 2025-March 2026 as against Tk. 1.23 for July 2024-March 2025. NOCFPS was Tk. (0.05) for July 2025-March 2026 as against Tk. (2.11) for July 2024-March 2025. NAV per share was Tk. 80.18 as on March 31, 2026 and Tk. 80.14 as on June 30, 2025. (cont.1)
ECABLES: Q3 Financials
(Q3 Un-audited): EPS was Tk. (1.74) for January-March 2026 as against Tk. (1.31) for January-March 2025; EPS was Tk. (3.70) for July 2025-March 2026 as against Tk. (3.45) for July 2024-March 2025. NOCFPS was Tk. 3.94 for July 2025-March 2026 as against Tk. 0.09 for July 2024-March 2025. NAV per share was Tk. 336.80 as on March 31, 2026 and Tk. 339.32 as on June 30, 2025. (cont.)
SHAHJABANK: Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 1.12 for January-March 2026 as against Tk. 1.04 for January-March 2025. Consolidated NOCFPS was Tk. 3.07 for January-March 2026 as against Tk. 4.36 for January-March 2025. Consolidated NAV per share was Tk. 24.09 as on March 31, 2026 and Tk. 22.02 as on March 31, 2025. (cont.)
TOSRIFA: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.08 for January-March 2026 as against Tk. 0.20 for January-March 2025; EPS was Tk. 0.25 for July 2025-March 2026 as against Tk. 0.47 for July 2024-March 2025. NOCFPS was Tk. (1.80) for July 2025-March 2026 as against Tk. 2.86 for July 2024-March 2025. NAV per share was Tk. 31.37 as on March 31, 2026 and Tk. 31.52 as on June 30, 2025. (cont.)
MJLBD: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 2.05 for January-March 2026 as against Tk. 1.43 for January-March 2025; Consolidated EPS was Tk. 5.91 for July 2025-March 2026 as against Tk. 8.09 for July 2024-March 2025. Consolidated NOCFPS was Tk. 15.83 for July 2025-March 2026 as against Tk. 0.29 for July 2024-March 2025. Consolidated NAV per share was Tk. 54.78 as on March 31, 2026 and Tk. 54.06 as on June 30, 2025. (cont.)
DSSL: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.09) for January-March 2026 as against Tk. 0.02 for January-March 2025; EPS was Tk. (0.13) for July 2025-March 2026 as against Tk. 0.37 for July 2024-March 2025. NOCFPS was Tk. 0.06 for July 2025-March 2026 as against Tk. 0.17 for July 2024-March 2025. NAV per share was Tk. 18.02 as on March 31, 2026 and Tk. 18.18 as on June 30, 2025.
DOREENPWR: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 1.11 for January-March 2026 as against Tk. 1.04 for January-March 2025; Consolidated EPS was Tk. 4.16 for July 2025-March 2026 as against Tk. 3.05 for July 2024-March 2025. Consolidated NOCFPS was Tk. 4.84 for July 2025-March 2026 as against Tk. 11.28 for July 2024-March 2025. Consolidated NAV per share was Tk. 56.26 as on March 31, 2026 and Tk. 52.43 as on June 30, 2025. (cont.)
DULAMIACOT: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.09) for January-March 2026 as against Tk. 0.02 for January-March 2025; EPS was Tk. 0.20 for July 2025-March 2026 as against Tk. 0.24 for July 2024-March 2025. NOCFPS was Tk. (0.23) for July 2025-March 2026 as against Tk. 0.26 for July 2024-March 2025. NAV per share was Tk. (39.87) as on March 31, 2026 and Tk. (39.83) as on June 30, 2025.
ACMELAB: Q3 Financials
(Q3 Un-audited): EPS was Tk. 3.30 for January-March 2026 as against Tk. 2.81 for January-March 2025; EPS was Tk. 9.40 for July 2025-March 2026 as against Tk. 8.28 for July 2024-March 2025. NOCFPS was Tk. 19.78 for July 2025-March 2026 as against Tk. 7.76 (restated) for July 2024-March 2025. NAV per share was Tk. 132.27 as on March 31, 2026 and Tk. 126.37 as on June 30, 2025. (cont.)
IFADAUTOS: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.15 for January-March 2026 as against Tk. 0.12 for January-March 2025; EPS was Tk. 0.32 for July 2025-March 2026 as against Tk. 0.37 for July 2024-March 2025. NOCFPS was Tk. 2.51 for July 2025-March 2026 as against Tk. 0.44 for July 2024-March 2025. NAV per share was Tk. 35.79 as on March 31, 2026 and Tk. 35.56 as on June 30, 2025.
ACIFORMULA: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 1.76 for January-March 2026 as against Tk. 1.89 for January-March 2025; Consolidated EPS was Tk. 8.26 for July 2025-March 2026 as against Tk. 8.65 for July 2024-March 2025. Consolidated NOCFPS was Tk. (6.79) for July 2025-March 2026 as against Tk. 3.53 for July 2024-March 2025. Consolidated NAV per share was Tk. 81.27 as on March 31, 2026 and Tk. 75.51 as on June 30, 2025. (cont.1)
KOHINOOR: Q3 Financials
(Q3 Un-audited): EPS was Tk. 4.18 for January-March 2026 as against Tk. 4.14 for January-March 2025; EPS was Tk. 12.28 for July 2025-March 2026 as against Tk. 10.39 for July 2024-March 2025. NOCFPS was Tk. 18.01 for July 2025-March 2026 as against Tk. 22.70 for July 2024-March 2025. NAV per share was Tk. 65.27 as on March 31, 2026 and Tk. 59.24 as on June 30, 2025.
ITC: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.92 for January-March 2026 as against Tk. 1.07 for January-March 2025; EPS was Tk. 2.70 for July 2025-March 2026 as against Tk. 3.00 for July 2024-March 2025. NOCFPS was Tk. 2.63 for July 2025-March 2026 as against Tk. 4.10 for July 2024-March 2025. NAV per share was Tk. 24.75 as on March 31, 2026 and Tk. 23.25 as on June 30, 2025.
SONARGAON: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.03) for January-March 2026 as against Tk. 0.22 for January-March 2025; EPS was Tk. (0.19) for July 2025-March 2026 as against Tk. 0.03 for July 2024-March 2025. NOCFPS was Tk. 4.56 for July 2025-March 2026 as against Tk. (0.02) for July 2024-March 2025. NAV per share was Tk. 18.16 as on March 31, 2026 and Tk. 18.35 as on June 30, 2025.
PHARMAID: Q3 Financials
(Q3 Un-audited): EPS was Tk. 6.11 for January-March 2026 as against Tk. 4.45 for January-March 2025; EPS was Tk. 20.20 for July 2025-March 2026 as against Tk. 15.77 for July 2024-March 2025. NOCFPS was Tk. 13.00 for July 2025-March 2026 as against Tk. 5.58 for July 2024-March 2025. NAV per share was Tk. 155.55 as on March 31, 2026 and Tk. 138.58 as on June 30, 2025. (cont.)
VFSTDL: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.01 for January-March 2026 as against Tk. 0.04 for January-March 2025; EPS was Tk. 0.03 for July 2025-March 2026 as against Tk. 0.10 for July 2024-March 2025. NOCFPS was Tk. 0.04 for July 2025-March 2026 as against Tk. (0.06) for July 2024-March 2025. NAV per share was Tk. 20.35 as on March 31, 2026 and Tk. 20.34 as on June 30, 2025.
BGIC: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.04.2026) following its corporate declaration.
BGIC: Dividend Declaration
The Board of Directors has recommended 11% Cash Dividend for the year ended December 31, 2025. Date of AGM: 18.06.2026, Time: 11:00 AM, Venue/Mode: Digital Platform (Zoom Link) and in person at Head Office, 42, Dilkusha C/A, Dhaka-1000, Record Date: 21.05.2026. The Company has also reported EPS of Tk. 1.51, NAV per share of Tk. 19.54 and NOCFPS of Tk. 0.60 for the year ended December 31, 2025 as against Tk. 1.40, Tk. 19.25 and Tk. 1.57 respectively for the year ended December 31, 2024.
MIRAKHTER: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 0.06 for January-March 2026 as against Tk. 0.27 for January-March 2025; Consolidated EPS was Tk. 0.66 for July 2025-March 2026 as against Tk. 1.00 for July 2024-March 2025. Consolidated NOCFPS was Tk. 1.34 for July 2025-March 2026 as against Tk. 7.15 for July 2024-March 2025. Consolidated NAV per share (with revaluation) was Tk. 51.63 as on March 31, 2026 and Tk. 51.51 as on June 30, 2025.